Index of reports
> Cases with Bradyphrenia (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Naloxone where reactions include bradyphrenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Naloxone side effects in female
Reported by a pharmacist from Italy on 2012-02-28
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naloxone
Dosage: strenght: 10 mg + 5 mg; daily dose: 2 posologic units
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Zoloft
Dosage: one posologic unit
Administration route: Oral
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Clonazepam
Dosage: 15 anz
Administration route: Oral
Start date: 2006-01-17
End date: 2011-07-11
Pramipexole Dihydrochloride
Dosage: 0.54 mg
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Topamax
Dosage: one posologic unit
Administration route: Oral
Start date: 2011-02-01
End date: 2011-07-11
Duloxetine Hydrochloride
Dosage: 60 mg
Administration route: Oral
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Coumadin; Nebivolol HCL; Levothyroxine Sodium; Furosemide; Esopral
Possible Naloxone side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-27
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clonazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2006-01-17
End date: 2011-07-11
Pramipexole Dihydrochloride
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Duloxetine Hydrochloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Zoloft
Administration route: Oral
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Topamax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Naloxone
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Coumadin; Nebivolol HCL; Furosemide; Levothyroxine Sodium; Esopral
Possible Naloxone side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-16
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pramipexole Dihydrochloride
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Naloxone
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Duloxetine Hydrochloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Clonazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2006-01-17
End date: 2011-07-11
Topamax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Zoloft
Administration route: Oral
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Levothyroxine Sodium; Furosemide; Esopral; Nebivolol HCL; Coumadin
Possible Naloxone side effects in female
Reported by a physician from Italy on 2012-02-09
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Topamax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Naloxone
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Clonazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2006-01-17
End date: 2011-07-11
Zoloft
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Pramipexole Dihydrochloride
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Duloxetine Hydrochloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Esomeprazole; Levothyroxine Sodium; Coumadin; Furosemide; Nebivolol HCL
Possible Naloxone side effects in female
Reported by a pharmacist from Italy on 2012-02-08
Patient: female
Reactions: Confusional State, Bradykinesia, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naloxone
Dosage: strenght: 10 mg + 5 mg; daily dose: 2 posologic units
Administration route: Oral
Indication: Radiculopathy
Start date: 2011-02-01
End date: 2011-07-11
Clonazepam
Dosage: 15 anz
Administration route: Oral
Start date: 2006-01-17
End date: 2011-07-11
Topamax
Dosage: one posologic unit
Administration route: Oral
Start date: 2011-02-01
End date: 2011-07-11
Duloxetine Hydrochloride
Dosage: 60 mg
Administration route: Oral
Start date: 2011-02-01
End date: 2011-07-11
Pramipexole Dihydrochloride
Dosage: 0.54 mg
Administration route: Oral
Indication: Restless Legs Syndrome
Start date: 2007-04-29
End date: 2011-07-16
Zoloft
Dosage: one posologic unit
Administration route: Oral
Indication: Depression
Start date: 2011-02-01
End date: 2011-07-11
Other drugs received by patient: Coumadin; Esopral; Furosemide; Nebivolol HCL; Levothyroxine Sodium
|